EAM
CVS icon

Empirical Asset Management’s CVS Health CVS Stock Holding History

Empirical Asset Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,752
Closed -$254K – 323
2025
Q1 		$254K Sell
3,752
-33,133
-90% -$1.98M 0.09% 270
2024
Q4 		$194K Buy
36,885
+32,860
+816% +$1.84M 0.06% 309
2024
Q3 		$253K Sell
4,025
-3,637
-47% -$212K 0.09% 255
2024
Q2 		$453K Sell
7,662
-3,720
-33% -$233K 0.17% 178
2024
Q1 		$726K Buy
11,382
+7,285
+178% +$556K 0.35% 77
2023
Q4 		$323K Buy
4,097
+6
+0.1% +$427 0.26% 127
2023
Q3 		$286K Sell
4,091
-61
-1% -$4.32K 0.25% 125
2023
Q2 		$287K Sell
4,152
-98
-2% -$6.97K 0.25% 119
2023
Q1 		$316K Sell
4,250
-6,793
-62% -$570K 0.3% 105
2022
Q4 		$387K Buy
11,043
+6,336
+135% +$611K 0.41% 97
2022
Q3 		$449K Sell
4,707
-362
-7% -$35.8K 0.49% 84
2022
Q2 		$470K Buy
5,069
+920
+22% +$89.8K 0.5% 63
2022
Q1 		$420K Sell
4,149
-5,240
-56% -$550K 0.4% 89
2021
Q4 		$969K Buy
+9,389
New +$868K 0.94% 31

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Empirical Asset Management's CVS Position: Q2 2025 in Review

Empirical Asset Management sold out of CVS Health (CVS) in Q2 2025, closing a stake of 3,752 shares — an estimated $254K sold.

Empirical Asset Management first reported a position in CVS in Q4 2021 and held it in 14 quarters. The position peaked at $969K in Q4 2021. 1,757 funds tracked by Wall St. Rank hold CVS as of Q2 2025.

  • Empirical Asset Management reported no remaining CVS Health position as of Q2 2025 after selling out during the quarter.
  • Empirical Asset Management sold 3,752 CVS Health shares in Q2 2025, an estimated $254K.
  • Empirical Asset Management first reported a position in CVS Health in Q4 2021 and held it in 14 quarters.
  • Empirical Asset Management's CVS Health position peaked at $969K in Q4 2021.
  • 1,757 funds tracked by Wall St. Rank held CVS Health as of Q2 2025.

Based on Empirical Asset Management's 13F filing for Q2 2025, filed 29 Jul 2025.